CAT and Hepatic fibrosis: The treatment with atorvastatin ameliorated liver fibrosis in the BDL+At group by the down-regulation of Rac1-GTP, Rac1, and NOX1, as well as the elevation of antioxidant molecules (thiols, SOD, and catalase).